These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4241158)

  • 1. The role of c'1q, cations, and ionic strength in the formation of C'1 esterase.
    Ratnoff OD; Naff GB
    J Lab Clin Med; 1969 Sep; 74(3):380-8. PubMed ID: 4241158
    [No Abstract]   [Full Text] [Related]  

  • 2. The conversion of C'IS to C'1 esterase by plasmin and trypsin.
    Ratnoff OD; Naff GB
    J Exp Med; 1967 Feb; 125(2):337-58. PubMed ID: 4225264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatographic resolution of the first component of human complement into three activities.
    LEPOW IH; NAFF GB; TODD EW; PENSKY J; HINZ CF
    J Exp Med; 1963 Jun; 117(6):983-1008. PubMed ID: 13929797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enzymatic nature of C'1r. Conversion of C'1s to C'1 esterase and digestion of amino acid esters by C'1r.
    Naff GB; Ratnoff OS
    J Exp Med; 1968 Oct; 128(4):571-93. PubMed ID: 5675434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.
    Ratnoff OD; Pensky J; Ogston D; Naff GB
    J Exp Med; 1969 Feb; 129(2):315-31. PubMed ID: 4178758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema.
    Klemperer MR; Donaldson VH; Rosen FS
    J Clin Invest; 1968 Mar; 47(3):604-11. PubMed ID: 4170149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.
    NAFF GB; PENSKY J; LEPOW IH
    J Exp Med; 1964 Apr; 119(4):593-613. PubMed ID: 14151101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMPLEMENT AS A MEDIATOR OF INFLAMMATION. ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE.
    RATNOFF OD; LEPOW IH
    J Exp Med; 1963 Nov; 118(5):681-98. PubMed ID: 14087615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.
    MUELLER-EBERHARD HJ; LEPOW IH
    J Exp Med; 1965 May; 121(5):819-33. PubMed ID: 14280442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of activation of C'1 esterase in hereditary angioneurotic edema plasma in vitro.
    Donaldson VH
    J Exp Med; 1968 Mar; 127(3):411-29. PubMed ID: 5299945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STUDIES ON HUMAN C'1-ESTERASE. II. FUNCTION OF PURIFIED C'1-ESTERASE IN THE HUMAN COMPLEMENT SYSTEM.
    HAINES AL; LEPOW IH
    J Immunol; 1964 Mar; 92():468-78. PubMed ID: 14131465
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on immune cellular injury. II. Functional role of C'1 esterase in immune cytotoxicity.
    LEPOW IH; ROSS A
    J Exp Med; 1960 Dec; 112(6):1107-20. PubMed ID: 13761024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylatoxin formation by purified human C'1 esterase.
    Dias da Silva W; Lepow IH
    J Immunol; 1965 Dec; 95(6):1080-9. PubMed ID: 4158798
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of calcium ions on the inactivation of human complement and its components by plasmin.
    LEPOW IH; PILLEMER L; RATNOFF OD
    J Exp Med; 1953 Sep; 98(3):277-89. PubMed ID: 13084846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the esterase activities of trypsin, plasmin, and thrombin on guanidinobenzoate esters. Titration of the enzymes.
    Chase T; Shaw E
    Biochemistry; 1969 May; 8(5):2212-24. PubMed ID: 4239491
    [No Abstract]   [Full Text] [Related]  

  • 16. STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.
    HAINES AL; LEPOW IH
    J Immunol; 1964 Mar; 92():456-67. PubMed ID: 14128991
    [No Abstract]   [Full Text] [Related]  

  • 17. The differentiation of esterase and fibrinolytic activity in human plasma euglobulin preparations.
    Harpel P
    Thromb Diath Haemorrh; 1968 Jul; 19(3):596-8. PubMed ID: 4236827
    [No Abstract]   [Full Text] [Related]  

  • 18. Agglutinating activity of the complement component C'1q in the F-II latex fixation test.
    Ewald RW; Schubart AF
    J Immunol; 1966 Jul; 97(1):100-5. PubMed ID: 4958549
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversible loss of activity of the first component of complement (C'1) as a function of ionic strength.
    Colten HR; Borsos T; Rapp HJ
    J Immunol; 1968 Apr; 100(4):799-807. PubMed ID: 5645221
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. I. The requirement for a factor resembling C'1 and the role of Ca++.
    LEPOW IH; WURZ L; RATNOFF OD; PILLEMER L
    J Immunol; 1954 Sep; 73(3):146-58. PubMed ID: 13201755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.